Development of a Self-Complementary AAV.U7snRNA Vector for Efficient Dystrophin Exon 53 Skipping

被引:0
|
作者
Qian, Randolph [1 ]
Foltz, Steven J. [1 ]
Jin, Lan [1 ]
Chen, Ting [1 ]
Qiao, Chunping [1 ]
Elliott, Kirk W. [1 ]
Hafiz, Ikram [1 ]
Yang, Jason [1 ]
Karumuthil-Melethil, Subha [1 ]
Bruder, Joseph T. [1 ]
Danos, Olivier F. [1 ]
Liu, Ye [1 ]
机构
[1] REGENXBIO, Res Early Dev, Rockville, MD USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
1565
引用
收藏
页码:736 / 736
页数:1
相关论文
共 41 条
  • [31] A single neonatal injection of an AAV9.U7snRNA virus mediating skipping of dmd exon 2 allows dystrophin expression preventing apparition of pathologic features in the Dup2 mouse one year post injection
    Wein, N.
    Simmons, T.
    Gumienny, F.
    Huang, N.
    Heller, K.
    Yurkoski, J.
    Rodino-Klapac, L.
    Muntoni, F.
    Flanigan, K.
    NEUROMUSCULAR DISORDERS, 2017, 27 : S187 - S187
  • [32] Characterization and Exploration of Treatment in a Novel Mouse Model of Duchenne Muscular Dystrophy Using Adeno-Associated-Virus.U7snRNA Mediated Exon Skipping of a Dystrophin Mutation Hot Spot
    Lesman, Daniel
    Rajakumar, Dhanarajan
    Al-Tabosh, Hayat
    Li, Ding
    Rafferty, Rachel
    Rodriguez, Yacidzohara
    Young, Courtney
    Spencer, Melissa
    Wein, Nicolas
    MOLECULAR THERAPY, 2020, 28 (04) : 325 - 325
  • [33] AAV.U7 technology for two mutational hotspots of the DMD gene (∼6%) results in efficient exon skipping, protein restoration and force improvement
    Wein, N.
    Simmons, T.
    Rajakumar, D.
    Lesman, D.
    Li, D.
    Gaffney, C.
    Rafferty, R.
    Huang, N.
    Rodriguez, Y.
    Young, C.
    Spencer, M.
    Flanigan, K.
    NEUROMUSCULAR DISORDERS, 2020, 30 : S107 - S107
  • [34] Dose escalation studies of rAAV9 U7snRNA targeting exon 2 show highly efficient skipping in the Dup2 mouse
    Simmons, T.
    Wein, N.
    Vulin-Chaffiol, A.
    Heller, K.
    Rutherford, A.
    Shontz, K.
    Flanigan, K.
    NEUROMUSCULAR DISORDERS, 2014, 24 (9-10) : 823 - 824
  • [35] Efficient Protection of Retina By Tyrosine-Mutated Self-Complementary AAV2 Vector Encoding BDNF in a Rat Retinal Ischemic Injury Model
    Igarashi, Tsutomu
    Miyake, Koichi
    Kobayashi, Maika
    Takahashi, Kazuhisa
    Miyake, Noriko
    Iijima, Osamu
    Nakamoto, Kenji
    Hirai, Yukihiko
    Shimada, Takashi
    Takahashi, Hiroshi
    MOLECULAR THERAPY, 2014, 22 : S47 - S47
  • [36] Intravenous Delivery of a rAAV9 U7snRNA Vector Targeting Exon 2 Results in Widespread Dystrophin Expression in the Dup2 DMD mouse model
    Simmons, Tabatha R.
    Vulin, Adeline
    Wein, Nicolas
    Rutherford, Andrea M.
    Janssen, Paul M.
    Flanigan, Kevin M.
    MOLECULAR THERAPY, 2014, 22 : S51 - S51
  • [37] Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates
    Nathwani, Amit C.
    Gray, John T.
    McIntosh, Jenny
    Ng, Catherine Y. C.
    Zhou, Junfang
    Spence, Yunyu
    Cochrane, Melanie
    Gray, Elaine
    Tuddenham, Edward G. D.
    Davidoff, Andrew M.
    BLOOD, 2007, 109 (04) : 1414 - 1421
  • [38] In Vivo Delivery of AAV.U7 Induce Efficient Exon Skipping for a Mutational Hotspot of the DMD Gene Results in Protein Restoration & Force Improvement in Skeletal Muscles, Heart & Diaphragm
    Rajakumar, Dhanarajan
    Li, Ding
    Lesman, Daniel
    Gaffney, Caleb
    Rodriguez, Yacidzohara
    Young, Courtney
    Spencer, Melissa J.
    Flanigan, Kevin M.
    Wein, Nicolas
    MOLECULAR THERAPY, 2021, 29 (04) : 126 - 126
  • [39] Preliminary evaluation of a self-complementary AAV2/8 vector for hepatic gene transfer of human apoE3 to inhibit atherosclerotic lesion development in apoE-deficient mice
    Osman, Eyman
    Evans, Vanessa
    Graham, Ian R.
    Athanasopoulos, Takis
    McIntosh, Jenny
    Nathwani, Amit C.
    Simons, J. Paul
    Dickson, George
    Owen, James S.
    ATHEROSCLEROSIS, 2009, 204 (01) : 121 - 126
  • [40] AAV.U7.ex44 mediates efficient exon skipping, protein restoration & phenotype rescue - pre-clinical intramuscular and dose escalation study for a mutational hotspot of the Duchenne muscular dystrophy (DMD)
    Rajakumar, D.
    Almeida, C.
    Atre, C.
    Lesman, D.
    Li, D.
    Rodriguez, Y.
    Young, C.
    Spencer, M.
    Flanigan, K.
    Wein, N.
    NEUROMUSCULAR DISORDERS, 2024, 43